Efficacy and Safety of First-Line TKI Plus ICI Therapy in Metastatic Non-Clear Cell Renal Cell Carcinoma: A Real-World Multiple-Centre Study.
Immuno-Oncology and Technology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Immuno-Oncology and Technology(2024)